Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial
Standard
Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial. / Bixby, Dale; Noppeney, Richard; Lin, Tara L; Cortes, Jorge; Krauter, Jürgen; Yee, Karen; Medeiros, Bruno C; Krämer, Alwin; Assouline, Sarit; Fiedler, Walter; Dimier, Natalie; Simmons, Brian P; Riehl, Todd; Colburn, Dawn.
in: BRIT J HAEMATOL, Jahrgang 185, Nr. 3, 05.2019, S. 595-598.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial
AU - Bixby, Dale
AU - Noppeney, Richard
AU - Lin, Tara L
AU - Cortes, Jorge
AU - Krauter, Jürgen
AU - Yee, Karen
AU - Medeiros, Bruno C
AU - Krämer, Alwin
AU - Assouline, Sarit
AU - Fiedler, Walter
AU - Dimier, Natalie
AU - Simmons, Brian P
AU - Riehl, Todd
AU - Colburn, Dawn
PY - 2019/5
Y1 - 2019/5
KW - Letter
U2 - 10.1111/bjh.15571
DO - 10.1111/bjh.15571
M3 - SCORING: Journal article
C2 - 30203489
VL - 185
SP - 595
EP - 598
JO - BRIT J HAEMATOL
JF - BRIT J HAEMATOL
SN - 0007-1048
IS - 3
ER -